Table 2 Characteristics of patients who developed mild asymptomatic hypercalcemia after vitamin D supplementation
| Patient no. | Group allocation | Baseline laboratory value | 12-week follow-up laboratory value | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Serum 25(OH)D (ng/mL) | eGFR (mL/min/1.73 m2) | Corrected serum calcium (mg/dL) | Serum phosphorus (mg/dL) | Serum 25(OH)D (ng/mL) | eGFR (mL/min/1.73 m2) | Corrected serum calcium (mg/dL) | Serum phosphorus (mg/dL) | ||
| 1 | Low-dose | 20.7 | 84.6 | 9.8 | 3.1 | 29.4 | 82.2 | 10.5 | 3.4 |
| 2 | High-dose | 17.4 | 42.6 | 10.1 | 3.5 | 45.0 | 43.3 | 11.1 | 3.7 |
| 3 | High-dose | 8.1 | 85.4 | 10.0 | 2.9 | 34.2 | 82.7 | 10.8 | 3.3 |